Limitations, agreements, and source contact

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease · Source last updated 2022-12-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

bouladf@MSKCC.ORG

organization

Memorial Sloan Kettering Cancer Center

phone

1-833-MSK-KIDS

title

Dr. Farid Boulad, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice